Why every country needs a strong National Cancer Control Plan 

National Cancer Control Plans (NCCPs) are overarching strategic frameworks developed by governments to establish priorities for cancer, including:

• Prevention
• Diagnosis
• Treatment
• Survivorship
• Palliative care

Crucially, their potential to drive meaningful improvements in cancer outcomes has been proven.

Prevention is a glaring omission

The International Cancer Control Partnership’s most recent global review of NCCPs found that only 30% of all cancer plans address prevention. This is a glaring omission, especially given that the cancer burden is already unsustainable – placing increasing pressure on over-stretched health systems and economies. Nearly half (40%) of all cancer cases are preventable by addressing modifiable risk factors including diet, weight, activity, alcohol, smoking and sun exposures, underscoring the fact that prevention is the sustainable way forward.

World Cancer Research Fund are on a mission to wave the flag for primary prevention. First off, Rachael Gormley, acting president of World Cancer Research Fund International, took part in a roundtable event about NCCPs at the recent World Economic Forum in Davos, Switzerland. Rachael took full advantage of this important platform to emphasise why prevention must be central to all cancer strategies.

We also welcomed the UK government’s call for evidence on the National Cancer Plan for England. Our primary goal is to ensure that the new plan places prevention and survivorship at its heart. We’ll be sharing our written submission in due course and look forward to collaborating with organisations across sectors to amplify our calls.

Plans can be force for positive change

The International Cancer Benchmarking Partnership has examined the relationship between cancer policies and survival rates. It found significant potential for NCCPs to improve cancer diagnosis, treatment, and outcomes when applied strategically and successively.

Countries that adopt this approach have experienced the greatest improvements in cancer survival. For example, Denmark, which implemented 4 consecutive plans between 2000 and 2020, has significantly improved the survival rates for multiple cancers, including an 19% increase in the 1-year survival rate for lung cancer over 15 years.

Prevention is crucial to the success of NCCPs as it offers the most effective and affordable long-term method of cancer control. Prevention policies range from interventions aimed at reducing risk factors, such as helping smokers quit, and policies to reduce overweight and obesity, to actions that tackle cancer-causing infections, such as human papilloma virus vaccination programmes.

While NCCPs are not a silver bullet, they present a unique opportunity to implement targeted, context-specific actions on a national scale. This is particularly important for prevention, where wide-ranging strategies can benefit from the streamlined and coordinated structure of NCCPs, which can set out a roadmap of action across the entire prevention continuum.

Bottom line is rising cancer burden

The growing global cancer burden is why NCCPs focused on prevention are needed.

The WHO estimates that nearly 1 in 6 deaths globally are caused by cancer each year, meaning that annually around 10 million people lose their lives to cancer. The latest statistics on global cancer rates also show that in 2022, there were 20 million new cancer diagnoses, and 53.5 million people living with or beyond cancer.

The enormity of these figures can make it difficult to remember that they represent real people who have had their lives turned upside down by cancer.

It isn’t only the human cost of cancer that is immense. The social and economic costs are also undeniable, making it particularly concerning that globally new cases are expected to skyrocket to 35 million annually by 2050. This increase will be felt most acutely in low- and middle-income countries, which are expected to experience a more rapid rise in cancer rates in the coming decades.

Fortunately, this worrying trajectory is not inevitable. A focus on cancer prevention in NCCPs would allow millions more people to live cancer free. It is also the most cost-effective way to tackle cancer and, crucially, reduces the need for expensive later stage treatments that are often inaccessible to many. In addition, it could lead to an array of co-benefits such as the prevention of other non-communicable diseases and a reduction in health inequalities.

While this shift to prevention requires systemic change coupled with sustained investment, the challenge is not insurmountable. Ultimately investment in prevention will have the highest pay off for governments and the good news is that we already know the integrated policy approach needed to make this a reality.

NCCPs are a meaningful tool to prevent cancer and improve survivorship, support health systems, and promote economic growth. We will continue making the case for prevention to ensure that NCCPs fulfil their potential to reduce the cancer burden. Alongside working to ensure the National Cancer Plan for England prioritises prevention, we will be calling for all countries to develop NCCPs that include meaningful prevention measures at the UN High-Level Meeting on non-communicable diseases in September.